# Comparing Bronchodilation of Symbicort With and Without Valved Holding Chamber (Aerochamber Plus)

> **NCT00915538** · PHASE4 · COMPLETED · sponsor: **Western Sky Medical Research** · enrollment: 16 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** pMDI budesonide/formotrol 160/4.5 is in group 1
- **DEVICE:** Symbicort 160/4.5 plus Aerochamber Plus included in group 2

## Key facts

- **NCT ID:** NCT00915538
- **Lead sponsor:** Western Sky Medical Research
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2020-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00915538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00915538, "Comparing Bronchodilation of Symbicort With and Without Valved Holding Chamber (Aerochamber Plus)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00915538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*